Pharmaceutical Commerce - June 2018 - 9

OV E RV I E W

volunteer effort to build a traceability
system called Qu4rtet. The intent is to
provide a modularized system, so that
some components (such as randomnumber generation) can be attached
in other traceability implementations.
The developers share their work at
a site called Serial-Lab.com, and the
software itself is available at a related
developers' site, gitlab.com. Vantage-
which does implementations and does
not sell software, is collaborating in the
effort, and has hopes of being hired
to implement the software for clients,
according to John Jordon, president.
TraceLink, generally regarded as
the largest Level 4 software developer, Fig. 2. Adents' vision and barcoding technology in action. Credit: Adents
is emphatically not giving its software
away; the company says that revenue in 2017 was up 85%
update, which were corrected as quickly as possible. And
over 2016, with 775 customers globally (including more
while no customer data was lost, he says, "we took some heat
than 180 who themselves serialize product; the others are
from customers, as we should." Going forward, the company
presumably trading partners managing serial number data),
recognizes its "mission critical" role in pharma production
and some 265,000 other companies have signed on to have
and distribution, and while TraceLink competitors heaped
accounts within the TraceLink Cloud.
scorn on the company, no one is tracking production hitches
TraceLink pioneered the use of multi-tenant architecture
at single-tenant or on-prem implementations.
in pharma traceability, and may be the only company still to
To some degree, with the proliferation of Level 4 vendors
use that form of cloud computing (many other vendors have
(see the Supplier Directory on pp. 32-33), and the maturation
single-tenant systems; the difference is that single-tenant
of the technology, traceability software is becoming harder
systems require each client to have its own "instance" of the
to differentiate. This also shows up in the fact that vendors
software, while TraceLink essentially runs one instance for
are now openly competing on price. Gurpreet Singh, head
the world). Surprisingly, although much of the corporate
of sales at Arvato Systems North America, notes that many
world (including IT systems for pharma R&D, managing
traceability vendors have a usage charge, based on how many
sales and marketing activities and other functions) is
serial numbers are being managed, in addition to whatever
using multi-tenant cloud systems, there is still resistance
subscription or site-license charge there might be-and then
among manufacturing IT managers, and on-premises
put another charge, based on transactions, on top of the first
implementations are still being performed.
two. "Arvato only charges for serial number usage once," he
The advantage of a multi-tenant architecture is
says. Arvato is the provider of the Corporate Serialization
that the provider can do one upgrade that is propagated
Database (CSDB); the system is a part of the SecurPharm
throughout the user base-which should translate into
hub, Germany's national hub under FMD, and has multiple
lower maintenance cost and less of an IT burden across
manufacturing or distribution clients as well.
the board. There was considerable buzz earlier this year
when a scheduled TraceLink update caused systems to be
Traceability at the edge
temporarily knocked offline. "This year, we've gone to a
As packaging lines are being geared up for DSCSA
very programmatic update schedule, with defined release
compliance, some industry attention is shifting to what
dates that are very predictable," says Brian Daleiden, VP at
happens in their own warehouses and at third-party logistics
the firm. There were "unexpected things" in the problem
providers (3PLs), who might be the next physical step in the

06.2018 / Visit our website at www.PharmaceuticalCommerce.com / 9


http://www.Serial-Lab.com http://www.gitlab.com http://www.PharmaceuticalCommerce.com

Table of Contents for the Digital Edition of Pharmaceutical Commerce - June 2018

Table of Contents
Pharmaceutical Commerce - June 2018 - Cover1
Pharmaceutical Commerce - June 2018 - Cover2
Pharmaceutical Commerce - June 2018 - Table of Contents
Pharmaceutical Commerce - June 2018 - 4
Pharmaceutical Commerce - June 2018 - 5
Pharmaceutical Commerce - June 2018 - 6
Pharmaceutical Commerce - June 2018 - 7
Pharmaceutical Commerce - June 2018 - 8
Pharmaceutical Commerce - June 2018 - 9
Pharmaceutical Commerce - June 2018 - 10
Pharmaceutical Commerce - June 2018 - 11
Pharmaceutical Commerce - June 2018 - 12
Pharmaceutical Commerce - June 2018 - 13
Pharmaceutical Commerce - June 2018 - 14
Pharmaceutical Commerce - June 2018 - 15
Pharmaceutical Commerce - June 2018 - 16
Pharmaceutical Commerce - June 2018 - 17
Pharmaceutical Commerce - June 2018 - 18
Pharmaceutical Commerce - June 2018 - 19
Pharmaceutical Commerce - June 2018 - 20
Pharmaceutical Commerce - June 2018 - 21
Pharmaceutical Commerce - June 2018 - 22
Pharmaceutical Commerce - June 2018 - 23
Pharmaceutical Commerce - June 2018 - 24
Pharmaceutical Commerce - June 2018 - 25
Pharmaceutical Commerce - June 2018 - 26
Pharmaceutical Commerce - June 2018 - 27
Pharmaceutical Commerce - June 2018 - 28
Pharmaceutical Commerce - June 2018 - 29
Pharmaceutical Commerce - June 2018 - 30
Pharmaceutical Commerce - June 2018 - 31
Pharmaceutical Commerce - June 2018 - 32
Pharmaceutical Commerce - June 2018 - 33
Pharmaceutical Commerce - June 2018 - 34
Pharmaceutical Commerce - June 2018 - Cover3
Pharmaceutical Commerce - June 2018 - Cover4
http://www.nxtbook.com/nxtbooks/pharmcomm/201909
http://www.nxtbook.com/nxtbooks/pharmcomm/201906
http://www.nxtbook.com/nxtbooks/pharmcomm/201903
http://www.nxtbook.com/nxtbooks/pharmcomm/201811
http://www.nxtbook.com/nxtbooks/pharmcomm/201809
http://www.nxtbook.com/nxtbooks/pharmcomm/201806
http://www.nxtbook.com/nxtbooks/pharmcomm/20180304
http://www.nxtbook.com/nxtbooks/pharmcomm/20171112
http://www.nxtbook.com/nxtbooks/pharmcomm/20170910
http://www.nxtbook.com/nxtbooks/pharmcomm/20170708
http://www.nxtbook.com/nxtbooks/pharmcomm/20170506
http://www.nxtbook.com/nxtbooks/pharmcomm/20170304
http://www.nxtbook.com/nxtbooks/pharmcomm/20170102
http://www.nxtbook.com/nxtbooks/pharmcomm/20161112
http://www.nxtbook.com/nxtbooks/pharmcomm/20160910
http://www.nxtbook.com/nxtbooks/pharmcomm/20160708
http://www.nxtbook.com/nxtbooks/pharmcomm/20160506
http://www.nxtbook.com/nxtbooks/pharmcomm/20160304
http://www.nxtbook.com/nxtbooks/pharmcomm/20160102
http://www.nxtbook.com/nxtbooks/pharmcomm/20151112
http://www.nxtbook.com/nxtbooks/pharmcomm/20150910
http://www.nxtbook.com/nxtbooks/pharmcomm/20150708
http://www.nxtbook.com/nxtbooks/pharmcomm/20150506
http://www.nxtbook.com/nxtbooks/pharmcomm/20150304
http://www.nxtbook.com/nxtbooks/pharmcomm/20150102
http://www.nxtbook.com/nxtbooks/pharmcomm/20141112
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchaindirectory2014
http://www.nxtbook.com/nxtbooks/pharmcomm/20140910
http://www.nxtbook.com/nxtbooks/pharmcomm/20140708
http://www.nxtbook.com/nxtbooks/pharmcomm/20140506
http://www.nxtbook.com/nxtbooks/pharmcomm/20140304
http://www.nxtbook.com/nxtbooks/pharmcomm/20140102
http://www.nxtbook.com/nxtbooks/pharmcomm/dataservicedirectory
http://www.nxtbook.com/nxtbooks/pharmcomm/20131112
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910_hubreport
http://www.nxtbook.com/nxtbooks/pharmcomm/20130910
http://www.nxtbook.com/nxtbooks/pharmcomm/20130708
http://www.nxtbook.com/nxtbooks/pharmcomm/20130506
http://www.nxtbook.com/nxtbooks/pharmcomm/coldchain2013
http://www.nxtbook.com/nxtbooks/pharmcomm/20130304
http://www.nxtbook.com/nxtbooks/pharmcomm/20130102
http://www.nxtbook.com/nxtbooks/pharmcomm/20121112
http://www.nxtbook.com/nxtbooks/pharmcomm/20120910
http://www.nxtbook.com/nxtbooks/pharmcomm/20120708
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506
http://www.nxtbook.com/nxtbooks/pharmcomm/20120506_coldchain
http://www.nxtbook.com/nxtbooks/pharmcomm/20120304
http://www.nxtbook.com/nxtbooks/pharmcomm/20120102
http://www.nxtbook.com/nxtbooks/pharmcomm/20111112
http://www.nxtbook.com/nxtbooks/pharmcomm/20110910
http://www.nxtbook.com/nxtbooks/pharmcomm/20110708
http://www.nxtbook.com/nxtbooks/pharmcomm/20110506
http://www.nxtbook.com/nxtbooks/pharmcomm/20110304
http://www.nxtbook.com/nxtbooks/pharmcomm/20110102
http://www.nxtbook.com/nxtbooks/pharmcomm/20101112
http://www.nxtbook.com/nxtbooks/pharmcomm/20100910
http://www.nxtbook.com/nxtbooks/pharmcomm/20100708
http://www.nxtbook.com/nxtbooks/pharmcomm/20100506
http://www.nxtbook.com/nxtbooks/pharmcomm/201004
http://www.nxtbook.com/nxtbooks/pharmcomm/201003
http://www.nxtbook.com/nxtbooks/pharmcomm/20100102
http://www.nxtbook.com/nxtbooks/pharmcomm/20091112
http://www.nxtbookMEDIA.com